Generic Name and Formulations:
Acetylcysteine 0.5g, 2.5g; effervescent tabs for oral soln; lemon-mint flavor; contains sodium bicarbonate.
Arbor Pharmaceuticals, LLC
Indications for CETYLEV:
To minimize hepatic injury after acetaminophen overdose in patients with acute ingestion or from repeated supratherapeutic ingestion (RSI).
Adults and Children:
Acute ingestion: assess history and timing of acetaminophen ingestion and obtain serum acetaminophen level at least 4hrs post-ingestion. If time of ingestion is unknown: give loading dose immediately and obtain acetaminophen level to determine need for continued treatment. If serum acetaminophen level unobtainable within 8hr interval or if toxicity evident: give loading dose immediately then continue for a total of 17 doses. If >8hrs post-ingestion and time of ingestion is known, give loading dose immediately and obtain acetaminophen level to determine need for continued treatment. If <8hrs post-ingestion and time of ingestion and the acetaminophen level are known, plot level on Rumack-Matthew nomogram to determine whether or not to initiate treatment (see full labeling). Loading dose: 140mg/kg. Maintenance dose: 70mg/kg every 4hrs for a total of 17 doses. May be administered by nasoduodenal tube or can consider IV form if unable to retain Cetylev. For weight-based dosage and others: see full labeling. RSI: obtain acetaminophen level and other lab tests for guidance; or, contact regional poison center.
Discontinue if hypersensitivity reactions occur unless necessary and reactions can be controlled. Risk of upper GI hemorrhage risk in those with esophageal varices or peptic ulcers. Monitor AST, ALT, bilirubin, INR, creatinine, BUN, blood glucose, electrolytes. CHF, hypertension, renal impairment: consider total sodium intake. Pregnancy. Nursing mothers.
Nausea, vomiting, other GI symptoms, rash with/without fever; upper GI hemorrhage.
Tabs—2x10 (blister packs)
Sign Up for Free e-newsletters
- Real World Results May Not Mirror Clinical Study Outcomes in Multiple Myeloma
- Is Radioimmunotherapy a Path Forward for Melanoma?
- Handling Chemotherapy Premedications
- FDA Approves Mogamulizumab-kpkc for Rare Subtypes of Non-Hodgkin Lymphoma
- New PDL1 Inhibitors for Non-small Cell Lung Cancer: Focus on Pembrolizumab
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Seeking Reliable Information on Herbal Products
- Disparities Remain in Prevalence of Cancer Screening Tests
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- 8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
- Combined Digital Screening Best for Detecting Breast Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|